Saturday, February 8, 2025
spot_imgspot_img

Top 5 This Week

spot_imgspot_img

Related Posts

Purdue Pharma and Sackler family agree to $7.4 billion settlement in OxyContin lawsuits


Purdue Pharma, along with members of the Sackler family who own the company, have agreed to a new settlement of up to $7.4 billion to resolve lawsuits related to the impact of the powerful prescription painkiller OxyContin. This settlement represents an increase of over $1 billion from a previous deal that was rejected by the U.S. Supreme Court. The deal, if approved by the courts, would be among the largest settlements reached in lawsuits related to the opioid crisis. The Sacklers will pay up to $6.5 billion, Purdue will pay $900 million, and the money will be used to compensate victims, address the opioid crisis, and provide treatment and overdose rescue medications.

The new settlement also includes provisions for the Sackler family to give up ownership of Purdue, which will become a new entity with its board appointed by states and other parties involved in the lawsuits. Some details of the settlement still need to be finalized, but the federal government is not expected to oppose the new deal, unlike the previous agreement. The settlement could bring an end to a long legal battle over the toll of the opioid crisis and the role of OxyContin, which has been linked to hundreds of thousands of deaths in the U.S. Members of the Sackler family have faced criticism for their involvement in Purdue, but they continue to deny any wrongdoing. The final details of the settlement are still being worked out, with parties seeking to extend a court order to prevent lawsuits against Sackler family members until February.

Photo credit
www.nbcnews.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles